This invention relates to novel substituted benzimidazoles and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a compound that modulates theGABAA receptor. This invention also provides novel intermediates for the preparation of the compounds of the invention, and salts thereof.
NOUVEAUX COMPOSES DE TYPE PHENYLAZETIDINE CARBOXYLATE OU CARBOXAMIDE
申请人:INVENTIVA
公开号:EP3107910A1
公开(公告)日:2016-12-28
[EN] NEW PHENYLAZETIDINE, CARBOXYLATE OR CARBOXAMIDE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES DE TYPE PHENYLAZETIDINE CARBOXYLATE OU CARBOXAMIDE
申请人:INVENTIVA
公开号:WO2015124868A1
公开(公告)日:2015-08-27
L'invention concerne les composés de formule (I) : dans laquelle R, R1, R2 n, A et Cy sont tels que définis dans la description. Les composés de formule (I) sont des modulateurs du récepteur NURR-1.
NEW PHENYLAZETIDINECARBOXYLATE OR -CARBOXAMIDE COMPOUNDS
申请人:INVENTIVA
公开号:US20170066717A1
公开(公告)日:2017-03-09
The invention relates to compounds of formula (I).
where R, R
1
, R
2
, n, A and Cy have the meanings indicated in the description.
The compounds of formula (I) are Nurr-1 modulators.